https://www.zacks.com/stock/news/2260507/watch-these-5-medical-stocks-for-q1-earnings-beat-or-miss?cid=CS-ZC-FT-analyst_blog|earnings_preview_-_esp-2260507
Apr 23, 2024 - Improved premiums resulting from membership growth, and higher patient admissions are expected to have driven the Q1 performance of HUM, MOH, UHS, EHC and CYH. An elevated operating expense level is likely to have dented growth prospects.
zc:-4270712098456522730
0
https://www.zacks.com/stock/news/2254801/molina-moh-wins-deal-to-serve-michigan-s-medicaid-members?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2254801
Apr 12, 2024 - Molina Healthcare (MOH) wins a Medicaid contract from the MDHHS to better care for the healthcare needs of Michigan's Medicaid beneficiaries and therefore, gain more customers.
zc:2802237097962694650
0
https://www.zacks.com/stock/news/2254020/centene-cnc-wins-medicaid-contract-to-better-serve-michigan?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2254020
Apr 11, 2024 - Centene's (CNC) Meridian secures a contract from the Michigan Department of Health and Human Services, which gives it the opportunity to better serve the health needs of the state's Medicaid members.
zc:-4998707533540684216
0
https://www.zacks.com/stock/news/2245867/how-to-boost-your-portfolio-with-top-medical-stocks-set-to-beat-earnings?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_earnings_esp-2245867
Mar 26, 2024 - Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
zc:-4522670912467777951
0
https://www.zacks.com/stock/news/2236169/the-joint-jynt-to-report-q4-earnings-here-are-the-key-drivers?cid=CS-ZC-FT-analyst_blog|earnings_preview-2236169
Mar 05, 2024 - The Joint's (JYNT) fourth-quarter 2023 results are likely to reflect higher expenses and patient volumes.
zc:3037389862078623070
0
https://www.zacks.com/commentary/2224560/3-hmo-stocks-in-focus-despite-high-tech-costs-nursing-shortage?cid=CS-ZC-FT-industry_outlook-2224560
Feb 12, 2024 - Growing customer base and M&A strategies are likely to aid the Medical-HMO industry. However, escalating expenses and a dearth in the availability of medical personnel are concerning. Stocks like CI, CNC and MOH are likely to navigate the industry storms.
zc:-8373077627387032583
0
https://www.zacks.com/stock/news/2223900/stock-market-news-for-feb-9-2024?cid=CS-ZC-FT-market_news-2223900
Feb 09, 2024 - Wall Street closed higher on Thursday as strong earnings data boosted market participants??? confidence on risky assets like equities.
zc:2577129338331173509
0
https://www.zacks.com/stock/news/2223634/molina-healthcare-moh-q4-earnings-beat-on-premium-growth?cid=CS-ZC-FT-analyst_blog|earnings_article-2223634
Feb 08, 2024 - Molina Healthcare (MOH) expects adjusted EPS to be at a minimum of $23.5 in 2024, which represents a year-over-year improvement of 12.5%.
zc:-9213798771273917717
0
https://www.zacks.com/stock/news/2222933/molina-moh-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2222933
Feb 07, 2024 - Although the revenue and EPS for Molina (MOH) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:460886173376920231
0
https://www.zacks.com/stock/news/2220201/gear-up-for-molina-moh-q4-earnings-wall-street-estimates-for-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2220201
Feb 02, 2024 - Besides Wall Street's top -and-bottom-line estimates for Molina (MOH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
zc:-5776680367563238780
0